Medizinisches Instrument und Herstellungsverfahren dafür

EP4740974 23. Januar 2025

Anmelder: Terumo Kabushiki Kaisha 🇯🇵

Details

Veröffentlichungs-Nr.
EP4740974
Anmeldetag
12. Juli 2024
Veröffentlichung
23. Januar 2025
Rechtsraum
EP
Offizieller Volltext

Abstract

Provided is a means configured to further improve antithrombogenicity in a medical device. A medical device of the present invention is a medical device including: a base material; an antithrombogenic layer including a polymer fixed to the base material, in which the polymer includes: a structural unit a derived from a first monomer bonded to the base material and including a reactive group that reacts with a hydroxyl group or a carboxyl group and an ethylenically unsaturated group; a structural unit B including a polymer chain including a structural unit b derived from a first antithrombogenic monomer including a carboxyl group and an ethylenically unsaturated group, and including a terminal of the polymer chain bonded to the structural unit a; and a structural unit C derived from a copolymer including a structural unit c1 derived from a second monomer including an amino group and bonded to the structural unit b and a structural unit c2 derived from a second antithrombogenic monomer.

Anmelder

Firma
Terumo Kabushiki Kaisha
Land
🇯🇵 Japan
🇯🇵 Terumo

Japanischer Medizintechnikkonzern mit Sitz in Tokio. Terumo entwickelt Produkte für Herz-Kreislauf-Systeme, Blutmanagement, Diabetesversorgung sowie medizinische Einwegprodukte und Spritzen.

4.021 Patente in unserer Datenbank

Noch Fragen?

Wir helfen Ihnen gerne weiter. Schreiben Sie uns einfach.

Kontakt aufnehmen